Hence, a “triple-hit” phenotype of MYChigh, BCL2high, and BCL6low has been proposed to confer an even worse prognosis in DLBCL than MYC+/BCL2+ cases. This evidence concerns the gene BCL2 and diffuse large B-cell lymphoma.